ARTICLE | Company News
Scripps Research Institute, Opko deal
October 12, 2015 7:00 AM UTC
Scripps granted Opko worldwide rights to develop and commercialize antibiotics that inhibit lipoprotein signal peptidase (LSPA). The antibiotics were discovered using a high throughput screening tech...